Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years

Shuman Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0228-3203; OpenAlex author ID A5101463619. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Co-author DOI 10.1038/s41420-024-01890-y↗
  2. CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Co-author DOI 10.1186/s13046-022-02443-w↗
  3. Pre-clinical Models of Metastasis in Pancreatic Cancer. First author DOI 10.3389/fcell.2021.748631↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christian P. Pilarsky · 3 shared papers, 2021–2024 · strength 0.49
  2. Hai Yang · 2 shared papers, 2022–2024 · strength 0.27
  3. Bin Lan · 2 shared papers, 2022–2024 · strength 0.27
  4. Nathalie Britzen‐Laurent · 2 shared papers, 2022–2024 · strength 0.27
  5. Robert Grützmann · 2 shared papers, 2022–2024 · strength 0.27
  6. Debabrata Mukhopadhyay · 2 shared papers, 2022–2024 · strength 0.27
  7. Andrew Victor Biankin · 2 shared papers, 2022–2024 · strength 0.27
  8. Maria Miquel · 1 shared paper, 2021 · strength 0.22
  9. Yanxi Lu · 1 shared paper, 2024 · strength 0.15
  10. Jinping Zhang · 1 shared paper, 2024 · strength 0.15
  11. Duo Yun · 1 shared paper, 2024 · strength 0.15
  12. Eva Lentsch · 1 shared paper, 2024 · strength 0.15
  13. Hang He · 1 shared paper, 2024 · strength 0.15
  14. Marc P. Stemmler · 1 shared paper, 2024 · strength 0.15
  15. Hao Yang · 1 shared paper, 2024 · strength 0.15
  16. Siyuan Zeng · 1 shared paper, 2022 · strength 0.13
  17. Peter J. Bailey · 1 shared paper, 2022 · strength 0.13
  18. Daniel Schreyer · 1 shared paper, 2022 · strength 0.13
  19. David Kuang-Fu Chang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.